Anticoagulant Market Research Report by Route of Administration (Injectable Anticoagulants and Oral Anticoagulants), by Anticoagulant Drug (Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis), by Drug Class, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Anticoagulant Market is expected to grow from USD 30,352.47 Million in 2020 to USD 46,946.45 Million by the end of 2025.
2. The Global Anticoagulant Market is expected to grow from EUR 26,613.63 Million in 2020 to EUR 41,163.54 Million by the end of 2025.
3. The Global Anticoagulant Market is expected to grow from GBP 23,659.57 Million in 2020 to GBP 36,594.48 Million by the end of 2025.
4. The Global Anticoagulant Market is expected to grow from JPY 3,239,378.74 Million in 2020 to JPY 5,010,376.90 Million by the end of 2025.
5. The Global Anticoagulant Market is expected to grow from AUD 44,075.83 Million in 2020 to AUD 68,172.50 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Anticoagulant to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Oral Anticoagulants is projected to witness the highest growth during the forecast period'
Based on Route of Administration, the Anticoagulant Market studied across Injectable Anticoagulants and Oral Anticoagulants. The Oral Anticoagulants commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Edoxaban / Rivaroxaban is projected to witness the highest growth during the forecast period'
Based on Anticoagulant Drug, the Anticoagulant Market studied across Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis. The Edoxaban / Rivaroxaban commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Heparin is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Anticoagulant Market studied across DTIs, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists. The DTIs commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Heparin is expected to grow at the fastest CAGR during the forecast period.
'The Deep Vein Thrombosis is projected to witness the highest growth during the forecast period'
Based on Application, the Anticoagulant Market studied across Atrial fibrillation & Heart Attack, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke. The Atrial fibrillation & Heart Attack commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Deep Vein Thrombosis is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Anticoagulant Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anticoagulant Market including Akebia Therapeutics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, Athenex, Inc., Baxter Laboratories Pty Ltd., Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sandoz International GmbH, Sanofi S.A., and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Anticoagulant Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Anticoagulant Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anticoagulant Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anticoagulant Market?
4. What is the competitive strategic window for opportunities in the Global Anticoagulant Market?
5. What are the technology trends and regulatory frameworks in the Global Anticoagulant Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anticoagulant Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Anticoagulant Market is expected to grow from USD 30,352.47 Million in 2020 to USD 46,946.45 Million by the end of 2025.
2. The Global Anticoagulant Market is expected to grow from EUR 26,613.63 Million in 2020 to EUR 41,163.54 Million by the end of 2025.
3. The Global Anticoagulant Market is expected to grow from GBP 23,659.57 Million in 2020 to GBP 36,594.48 Million by the end of 2025.
4. The Global Anticoagulant Market is expected to grow from JPY 3,239,378.74 Million in 2020 to JPY 5,010,376.90 Million by the end of 2025.
5. The Global Anticoagulant Market is expected to grow from AUD 44,075.83 Million in 2020 to AUD 68,172.50 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Anticoagulant to forecast the revenues and analyze the trends in each of the following sub-markets:
'The Oral Anticoagulants is projected to witness the highest growth during the forecast period'
Based on Route of Administration, the Anticoagulant Market studied across Injectable Anticoagulants and Oral Anticoagulants. The Oral Anticoagulants commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Edoxaban / Rivaroxaban is projected to witness the highest growth during the forecast period'
Based on Anticoagulant Drug, the Anticoagulant Market studied across Betrixaban, Dabigatran, Edoxaban / Rivaroxaban, and Eliquis. The Edoxaban / Rivaroxaban commanded the largest size in the Anticoagulant Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
'The Heparin is projected to witness the highest growth during the forecast period'
Based on Drug Class, the Anticoagulant Market studied across DTIs, Factor XA Inhibitors, Heparin, and Vitamin K Antagonists. The DTIs commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Heparin is expected to grow at the fastest CAGR during the forecast period.
'The Deep Vein Thrombosis is projected to witness the highest growth during the forecast period'
Based on Application, the Anticoagulant Market studied across Atrial fibrillation & Heart Attack, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke. The Atrial fibrillation & Heart Attack commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Deep Vein Thrombosis is expected to grow at the fastest CAGR during the forecast period.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Anticoagulant Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Anticoagulant Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Anticoagulant Market including Akebia Therapeutics, Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, Athenex, Inc., Baxter Laboratories Pty Ltd., Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, Eli Lilly and Company, Johnson & Johnson, Mylan N.V., Novartis AG, Pfizer Inc., Sandoz International GmbH, Sanofi S.A., and Teva Pharmaceutical Industries Ltd..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Anticoagulant Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Anticoagulant Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anticoagulant Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anticoagulant Market?
4. What is the competitive strategic window for opportunities in the Global Anticoagulant Market?
5. What are the technology trends and regulatory frameworks in the Global Anticoagulant Market?
6. What are the modes and strategic moves considered suitable for entering the Global Anticoagulant Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Anticoagulant Drug Outlook
3.4. Route of Administration Outlook
3.5. Drug Class Outlook
3.6. Application Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of venous thromboembolism and cardiovascular disorders
5.1.1.2. Growing number of elderly and obese people
5.1.1.3. Increasing acceptance of novel oral anticoagulants
5.1.2. Restraints
5.1.2.1. Stringent regulations related to drug dosage and clinical approvals
5.1.3. Opportunities
5.1.3.1. Introduction of novel anticoagulation therapeutics and increasing R&D investments
5.1.3.2. Increasing collaboration activities and development of generic drugs
5.1.4. Challenges
5.1.4.1. Potential risk associated with the side-effects and complications associated with the usage of oral anticoagulants
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTICOAGULANT MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Injectable Anticoagulants
6.3. Oral Anticoagulants
7. GLOBAL ANTICOAGULANT MARKET, BY ANTICOAGULANT DRUG
7.1. Introduction
7.2. Betrixaban
7.3. Dabigatran
7.4. Edoxaban / Rivaroxaban
7.5. Eliquis
8. GLOBAL ANTICOAGULANT MARKET, BY DRUG CLASS
8.1. Introduction
8.2. DTIs
8.3. Factor XA Inhibitors
8.4. Heparin
8.5. Vitamin K Antagonists
9. GLOBAL ANTICOAGULANT MARKET, BY APPLICATION
9.1. Introduction
9.2. Atrial fibrillation & Heart Attack
9.3. Deep Vein Thrombosis
9.4. Pulmonary Embolism
9.5. Stroke
10. AMERICAS ANTICOAGULANT MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ANTICOAGULANT MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Akebia Therapeutics, Inc.
14.2. Aspen Pharmacare Holdings Limited
14.3. AstraZeneca PLC
14.4. Athenex, Inc.
14.5. Baxter Laboratories Pty Ltd.
14.6. Bayer AG
14.7. C.H. Boehringer Sohn AG & Ko. KG
14.8. Eli Lilly and Company
14.9. Johnson & Johnson
14.10. Mylan N.V.
14.11. Novartis AG
14.12. Pfizer Inc.
14.13. Sandoz International GmbH
14.14. Sanofi S.A.
14.15. Teva Pharmaceutical Industries Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Anticoagulant Drug Outlook
3.4. Route of Administration Outlook
3.5. Drug Class Outlook
3.6. Application Outlook
3.7. Geography Outlook
3.8. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of venous thromboembolism and cardiovascular disorders
5.1.1.2. Growing number of elderly and obese people
5.1.1.3. Increasing acceptance of novel oral anticoagulants
5.1.2. Restraints
5.1.2.1. Stringent regulations related to drug dosage and clinical approvals
5.1.3. Opportunities
5.1.3.1. Introduction of novel anticoagulation therapeutics and increasing R&D investments
5.1.3.2. Increasing collaboration activities and development of generic drugs
5.1.4. Challenges
5.1.4.1. Potential risk associated with the side-effects and complications associated with the usage of oral anticoagulants
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL ANTICOAGULANT MARKET, BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Injectable Anticoagulants
6.3. Oral Anticoagulants
7. GLOBAL ANTICOAGULANT MARKET, BY ANTICOAGULANT DRUG
7.1. Introduction
7.2. Betrixaban
7.3. Dabigatran
7.4. Edoxaban / Rivaroxaban
7.5. Eliquis
8. GLOBAL ANTICOAGULANT MARKET, BY DRUG CLASS
8.1. Introduction
8.2. DTIs
8.3. Factor XA Inhibitors
8.4. Heparin
8.5. Vitamin K Antagonists
9. GLOBAL ANTICOAGULANT MARKET, BY APPLICATION
9.1. Introduction
9.2. Atrial fibrillation & Heart Attack
9.3. Deep Vein Thrombosis
9.4. Pulmonary Embolism
9.5. Stroke
10. AMERICAS ANTICOAGULANT MARKET
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. ASIA-PACIFIC ANTICOAGULANT MARKET
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. South Korea
11.10. Thailand
12. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. COMPETITIVE LANDSCAPE
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis
13.4. Competitor SWOT Analysis
13.5. Competitive Scenario
13.5.1. Merger & Acquisition
13.5.2. Agreement, Collaboration, & Partnership
13.5.3. New Product Launch & Enhancement
13.5.4. Investment & Funding
13.5.5. Award, Recognition, & Expansion
14. COMPANY USABILITY PROFILES
14.1. Akebia Therapeutics, Inc.
14.2. Aspen Pharmacare Holdings Limited
14.3. AstraZeneca PLC
14.4. Athenex, Inc.
14.5. Baxter Laboratories Pty Ltd.
14.6. Bayer AG
14.7. C.H. Boehringer Sohn AG & Ko. KG
14.8. Eli Lilly and Company
14.9. Johnson & Johnson
14.10. Mylan N.V.
14.11. Novartis AG
14.12. Pfizer Inc.
14.13. Sandoz International GmbH
14.14. Sanofi S.A.
14.15. Teva Pharmaceutical Industries Ltd.
15. APPENDIX
15.1. Discussion Guide
15.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTICOAGULANT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MEXICO ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. UNITED STATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. CHINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDONESIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDONESIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDONESIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. JAPAN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. JAPAN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. THAILAND ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. THAILAND ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. FRANCE ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. FRANCE ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. FRANCE ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. GERMANY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. GERMANY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. GERMANY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. ITALY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. ITALY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. ITALY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. QATAR ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. QATAR ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. RUSSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SPAIN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SPAIN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. GLOBAL ANTICOAGULANT MARKET: SCORES
TABLE 138. GLOBAL ANTICOAGULANT MARKET: BUSINESS STRATEGY
TABLE 139. GLOBAL ANTICOAGULANT MARKET: PRODUCT SATISFACTION
TABLE 140. GLOBAL ANTICOAGULANT MARKET: RANKING
TABLE 141. GLOBAL ANTICOAGULANT MARKET: MERGER & ACQUISITION
TABLE 142. GLOBAL ANTICOAGULANT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 143. GLOBAL ANTICOAGULANT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 144. GLOBAL ANTICOAGULANT MARKET: INVESTMENT & FUNDING
TABLE 145. GLOBAL ANTICOAGULANT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 146. GLOBAL ANTICOAGULANT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL ANTICOAGULANT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. AMERICAS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. BRAZIL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CANADA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. CANADA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. MEXICO ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. MEXICO ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. MEXICO ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. UNITED STATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. UNITED STATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED STATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. CHINA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. CHINA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. CHINA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. CHINA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. INDIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. INDIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. INDIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDONESIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDONESIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDONESIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDONESIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. JAPAN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. JAPAN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. JAPAN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. MALAYSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. MALAYSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. THAILAND ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. THAILAND ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. THAILAND ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. THAILAND ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. FRANCE ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. FRANCE ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. FRANCE ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. FRANCE ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. GERMANY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. GERMANY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. GERMANY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. GERMANY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. ITALY ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. ITALY ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. ITALY ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. ITALY ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. QATAR ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. QATAR ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. QATAR ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. QATAR ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. RUSSIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. RUSSIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. RUSSIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. RUSSIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 122. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 123. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 124. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 125. SPAIN ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 126. SPAIN ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 127. SPAIN ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 128. SPAIN ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 129. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 130. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 131. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 132. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 133. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 134. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 135. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 136. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 137. GLOBAL ANTICOAGULANT MARKET: SCORES
TABLE 138. GLOBAL ANTICOAGULANT MARKET: BUSINESS STRATEGY
TABLE 139. GLOBAL ANTICOAGULANT MARKET: PRODUCT SATISFACTION
TABLE 140. GLOBAL ANTICOAGULANT MARKET: RANKING
TABLE 141. GLOBAL ANTICOAGULANT MARKET: MERGER & ACQUISITION
TABLE 142. GLOBAL ANTICOAGULANT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 143. GLOBAL ANTICOAGULANT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 144. GLOBAL ANTICOAGULANT MARKET: INVESTMENT & FUNDING
TABLE 145. GLOBAL ANTICOAGULANT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 146. GLOBAL ANTICOAGULANT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL ANTICOAGULANT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTICOAGULANT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANTICOAGULANT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ANTICOAGULANT MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ANTICOAGULANT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2025
FIGURE 23. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 30. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 35. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2025
FIGURE 37. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, 2020 VS 2025 (USD MILLION)
FIGURE 41. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. ARGENTINA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. BRAZIL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. CANADA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MEXICO ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. UNITED STATES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 50. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 52. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. CHINA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. INDONESIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. JAPAN ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. MALAYSIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. THAILAND ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. FRANCE ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GERMANY ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. ITALY ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. QATAR ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. RUSSIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. SPAIN ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 77. GLOBAL ANTICOAGULANT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTICOAGULANT MARKET, BY TYPE
FIGURE 1. GLOBAL ANTICOAGULANT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL ANTICOAGULANT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 (USD MILLION)
FIGURE 5. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
FIGURE 6. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
FIGURE 7. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
FIGURE 8. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 9. GLOBAL ANTICOAGULANT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 10. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 11. GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 13. GLOBAL ANTICOAGULANT MARKET: MARKET DYNAMICS
FIGURE 14. GLOBAL ANTICOAGULANT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 15. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (%)
FIGURE 16. GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2025 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025
FIGURE 18. GLOBAL ANTICOAGULANT MARKET SIZE, BY INJECTABLE ANTICOAGULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL ANTICOAGULANT MARKET SIZE, BY ORAL ANTICOAGULANTS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2025 (%)
FIGURE 21. GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2020 VS 2025 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY ANTICOAGULANT DRUG, 2025
FIGURE 23. GLOBAL ANTICOAGULANT MARKET SIZE, BY BETRIXABAN, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL ANTICOAGULANT MARKET SIZE, BY DABIGATRAN, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL ANTICOAGULANT MARKET SIZE, BY EDOXABAN / RIVAROXABAN, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL ANTICOAGULANT MARKET SIZE, BY ELIQUIS, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (%)
FIGURE 28. GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 30. GLOBAL ANTICOAGULANT MARKET SIZE, BY DTIS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL ANTICOAGULANT MARKET SIZE, BY FACTOR XA INHIBITORS, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL ANTICOAGULANT MARKET SIZE, BY HEPARIN, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL ANTICOAGULANT MARKET SIZE, BY VITAMIN K ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
FIGURE 35. GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTICOAGULANT MARKET SIZE, BY APPLICATION, 2025
FIGURE 37. GLOBAL ANTICOAGULANT MARKET SIZE, BY ATRIAL FIBRILLATION & HEART ATTACK, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL ANTICOAGULANT MARKET SIZE, BY DEEP VEIN THROMBOSIS, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL ANTICOAGULANT MARKET SIZE, BY PULMONARY EMBOLISM, 2020 VS 2025 (USD MILLION)
FIGURE 40. GLOBAL ANTICOAGULANT MARKET SIZE, BY STROKE, 2020 VS 2025 (USD MILLION)
FIGURE 41. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 42. AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 43. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 44. ARGENTINA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. BRAZIL ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. CANADA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. MEXICO ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. UNITED STATES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 50. ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 51. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 52. AUSTRALIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. CHINA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. INDONESIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. JAPAN ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. MALAYSIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. PHILIPPINES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. SOUTH KOREA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. THAILAND ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 64. FRANCE ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. GERMANY ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. ITALY ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. NETHERLANDS ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. QATAR ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. RUSSIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SAUDI ARABIA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SOUTH AFRICA ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. SPAIN ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. UNITED KINGDOM ANTICOAGULANT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 75. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 76. GLOBAL ANTICOAGULANT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 77. GLOBAL ANTICOAGULANT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTICOAGULANT MARKET, BY TYPE
